Letter: loss of response to anti-TNFα agents depends on treatment duration in patients with inflammatory bowel disease—authors' reply

Mahmoud, Remi; Schultheiss, Johannes P.D.; Fidder, Herma H.; Oldenburg, Bas

doi:https://doi.org/10.1111/apt.16757

Letter: loss of response to anti-TNFα agents depends on treatment duration in patients with inflammatory bowel disease—authors' reply

DSpace/Manakin Repository

Letter: loss of response to anti-TNFα agents depends on treatment duration in patients with inflammatory bowel disease—authors' reply

Mahmoud, Remi; Schultheiss, Johannes P.D.; Fidder, Herma H.; Oldenburg, Bas

(2022) Alimentary Pharmacology and Therapeutics, volume 55, issue 4, pp. 499 - 500

(Comment)

Download/Full Text

The full text of this publication is not available.

Version on publisher website for UU-students and staff

Version on publisher website

Keywords: Chronic Disease, Duration of Therapy, Humans, Inflammatory Bowel Diseases/drug therapy, Gastroenterology, Pharmacology (medical), Hepatology, Comment, Letter

DOI: https://doi.org/10.1111/apt.16757

ISSN: 0269-2813

Publisher: Wiley-Blackwell

Note: Funding Information: The authors' declarations of personal and financial interests are unchanged from those in the original article.1

(Peer reviewed)